Fundz

Diakonos Oncology Names Ian H. Bellayr, Ph.D. Chief Regulatory Officer

PRIVATENov 20, 2023

Position

Chief Regulatory Officer

Company

Diakonos Oncology

Ian H. Bellayr
i.bellayr@diakonosoncology.com
HoustonBiotechnologyHealth CareMedicalTherapeutics

Description

Diakonos Oncology Corporation , a clinical stage immuno-oncology company, announced today that Ian H. Bellayr, Ph.D., a regulatory expert with the U.S. Food and Drug Administration and National Institutes of Health , has joined the company as its Chief Regulatory Officer.

Company Information

Company

Diakonos Oncology

Location

Houston, Texas, United States

About

Diakonos Oncology Corp. is a clinical stage immuno-oncology company based in Houston, TX. The company is at the forefront of developing dendritic cell vaccines that leverage a patient's immune system to target and eliminate cancer cells, mimicking the body's natural response to viral infections.

Fundz sees it the moment Diakonos Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Ian
Likely contact at this company
••••••••@••••••••

See Ian's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Diakonos Oncology's next move

Learn about Strategic plan

Diakonos Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.